Arkolith/Insider Trading/RLAY/Form 4

Bergstrom Donald A

President, R&DRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jan 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$167K
Net Open-Market Flow
-$167K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 28, 2026Sell(S)3K$8.45$23K420K
Jan 27, 2026Sell(S)19K$7.62$144K423K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-029415) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML